GSK, Astra, J&J link with universities in new drug research fund
January 25, 2016 at 02:46 AM EST
LONDON, Jan 25 (Reuters) - GlaxoSmithKline, AstraZeneca and Johnson & Johnson have joined with three leading British universities to create a new 40 million pounds ($57 million) fund backing early drug research.
